Chesshyre Emily, Wooding Eva, Sey Emily, Warris Adilia
MRC Centre for Medical Mycology, Department of Biosciences, Faculty of Health and Life Sciences, University of Exeter, Exeter EX4 4QD, UK.
Department of Paediatrics, Royal Devon University Healthcare NHS Foundation Trust, Exeter EX2 5DW, UK.
J Fungi (Basel). 2025 Mar 9;11(3):210. doi: 10.3390/jof11030210.
Cystic fibrosis is a severe, inherited, life-limiting disorder, and over half of those living with CF are children. Persistent airway infection and inflammation, resulting in progressive lung function decline, is the hallmark of this disorder. colonization and infection is a well-known complication in people with CF and can evolve in a range of disease phenotypes, including bronchitis, fungal sensitization, and allergic bronchopulmonary aspergillosis (ABPA). Management strategies for children with CF are primarily aimed at preventing lung damage and lung function decline caused by bacterial infections. The role of infections is less understood, especially during childhood, and therefore evidence-based diagnostic and treatment guidelines are lacking. This narrative review summarizes our current understanding of the impact of on the airways of children and young people with CF.
囊性纤维化是一种严重的、遗传性的、危及生命的疾病,超过一半的囊性纤维化患者是儿童。持续性气道感染和炎症导致肺功能进行性下降,是这种疾病的标志。定植和感染是囊性纤维化患者众所周知的并发症,可演变为一系列疾病表型,包括支气管炎、真菌致敏和变应性支气管肺曲霉病(ABPA)。囊性纤维化患儿的管理策略主要旨在预防细菌感染引起的肺损伤和肺功能下降。感染的作用尚不太清楚,尤其是在儿童时期,因此缺乏循证诊断和治疗指南。本叙述性综述总结了我们目前对[原文此处单词有误,推测可能是某种感染因素,暂以“[感染因素]”表示]对囊性纤维化儿童和青少年气道影响的理解。